NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-162

  1. 1,937 Posts.
    lightbulb Created with Sketch. 34
    Couldn’t tell you how many times I’ve refreshed that same page over the last few days and nights. Got me kicked out of bed and into the spare room last night…
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.